Media Relations
.
Media Relations
-
Schwabe invests 10 Mio USD in North American business
GREEN BAY, Wis., 22 October 2009. At a press conference with Wisconsin Governor Jim Doyle, Schwabe North America, Inc. announced an over 10 million US dollar expansion and consolidation of several of its operations into its Green Bay facility. In addition to extensively remodeling and upgrading the existing Labs, Product Development, Quality Control and Manufacturing divisions, a new 100,000 square foot distribution center is being completed. Scheduled to commence operations on December 1, 2009, it will distribute all the company’s brands including Nature’s Way®, Boericke & Tafel, Enzymatic Therapy, Integrative Therapeutics™ and PhytoPharmica®.
-
Dr. Willmar Schwabe Pharmaceuticals acquires Dr. Peithner Holding GmbH, Austria
KARLSRUHE, Germany, 22 April 2009. Dr. Willmar Schwabe Pharmaceuticals today announced the acquisition of the privately held Dr. Peithner Holding GmbH, Vienna, Austria. With this acquisition, Schwabe will expand its presence in Austria and Central & Eastern Europe (CEE).
-
Dr. Willmar Schwabe Pharmaceuticals Will Acquire Enzymatic Therapy, Inc., USA
KARLSRUHE, Germany, 10 October 2008. Nature's Way Holding Company, a subsidiary of German-based Dr. Willmar Schwabe Pharmaceuticals, a leading worldwide producer of clinically proven phytomedicines, has reached agreement to acquire all outstanding shares of Enzymatic Therapy with North Castle Partners, LLC, the controlling shareholder of Enzymatic Therapy. The agreement is subject to other shareholders delivering their signatures and provides for customary conditions to closing
Read On
;){kind=link}
;){kind=link}
Path Navigation
Main Navigation
Latest News
Major study shows that long-term intake of Ginkgo biloba special extract EGb 761® protects against Alzheimer's disease
Read more
Footer Navigation
Service Navigation
Help
You can change the Font Size here:
Font Size